...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model.
【24h】

Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model.

机译:通过T细胞频率分析和人皮肤外植体模型检测到的人脐血细胞的细胞同种异体反应性。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Recent clinical data have demonstrated the success of allogeneic stem cell transplantation using HLA-mismatched unrelated human umbilical cord blood (CB). The incidence and severity of acute graft-versus-host disease (GVHD) in these mainly pediatric transplants is low. The immunological mechanisms by which CB transplants may result in reduced GVHD is not completely clear. In this study, the functional cellular alloreactivity of CB cells was investigated, by measuring the frequency of alloreactive helper and cytotoxic T lymphocyte precursors (HTLp and CTLp, respectively) in CB and detecting the ability of CB cells to induce graft-versus-host (GVH) type alloreactivity in vitro. METHODS: A human skin explant model was used to measure GVH type alloreactivity in vitro. A combined limiting dilution assay was carried out in parallel to determine alloreactive HTLp and CTLp frequencies. The cellular alloreactivity was compared between cord and HLA-haploidentical parental blood cells against the same HLA-mismatched unrelated stimulator. RESULTS: The results demonstrated that alloreactive CTLp frequency in CB mononuclear cells (CBMCs) was significantly lower (mean, 1:35,694, range, 1:1,667-<1:500,000) than that in adult peripheral blood mononuclear cells (PBMCs) (mean, 1:5,333, range, 1:544-1:47,619). Alloreactive HTLp frequencies, however, were comparable for CBMCs and PBMCs (mean, 1:7,586, range, 1:1,359-1:200,000; and mean, 1:5,976, range, 1:385-1:50,000, respectively). A significantly decreased ability to induce in vitro GVH type alloreactivity was observed for CBMCs and that was strongly associated with low alloreactive CTLp frequencies (P=0.001). CONCLUSIONS: The present study provides the first clear in vitro evidence to suggest that CBMCs are less able than PBMCs to induce skin GVH type alloreactivity in HLA-mismatched pairs. The severity of in vitro GVH type alloreactivity (graded as I-IV) was strongly associated with the levels of alloreactive CTLp frequencies. The low cellular alloreactivity of CBMCs detected in vitro suggests that in a proportion of cases HLA-mismatched unrelated CB may not give rise to severe GVHD in vivo after transplantation.
机译:背景:最近的临床数据表明,使用HLA不匹配的无关人脐带血(CB)进行异体干细胞移植成功。在这些主要的小儿移植中,急性移植物抗宿主病(GVHD)的发生率和严重性较低。 CB移植可能导致GVHD降低的免疫机制尚不完全清楚。在这项研究中,通过测量CB中的同种反应性辅助细胞和细胞毒性T淋巴细胞前体(分别为HTLp和CTLp)的频率并检测CB细胞诱导移植物抗宿主的能力,研究了CB细胞的功能性细胞同种异体反应性( GVH)型异体反应。方法:使用人皮肤外植体模型体外测量GVH型同种异体反应。平行进行有限稀释联合测定,以确定同种异体反应性HTLp和CTLp频率。比较了脐带血和HLA单倍亲本血细胞对相同HLA不匹配的无关刺激物的细胞同种异体反应性。结果:结果表明,与成人外周血单个核细胞(PBMC)相比,CB单核细胞(CBMC)的同种反应性CTLp频率显着降低(平均值,为1:35,694,范围为1:1,667- <1:500,000)。 ,1:5,333,范围,1:544-1:47,619)。但是,CBMC和PBMC的同种异体反应性HTLp频率相当(平均值分别为1:7,586,范围为1:1,359-1:200,000;平均值为1:5,976,范围为1:385-1:50,000)。对于CBMC,观察到诱导体外GVH型同种反应性的能力明显降低,这与低同种反应性CTLp频率强烈相关(P = 0.001)。结论:本研究提供了第一个明确的体外证据,表明CBMCs不如PBMCs诱导HLA不匹配对中的皮肤GVH型同种异体反应。体外GVH型同种异体反应的严重程度(分级为I-IV)与同种异体CTLp频率水平密切相关。体外检测到的CBMC的低细胞同种异体反应性表明,在移植后,体内HLA错配的无关CB在一定比例的情况下可能不会在体内引起严重的GVHD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号